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Abstract. Differentiation and proliferation of hemato- 
poietic progenitors take place in the bone marrow and 
is a tightly controlled process. Cell adhesion molecules 
of the integrin and immunoglobulin families have been 
shown to be involved in these processes, but almost 
nothing was known about the involvement of the cad- 
herin family in the hematopoietic system. A  PCR 
screening of RNA of human bone marrow mononu- 
clear cells with specific primers for classical cadherins 
revealed that E-cadherin, which is mainly expressed by 
cells of epithelial origin, is also expressed by bone mar- 
row cells. Western blot analysis and immunofluores- 
cence staining of bone marrow sections confirmed this 
unexpected finding. A  more detailed analysis using im- 
munoaffinity columns and dual color flow cytometry 
showed that the expression of E-cadherin is restricted 
to defined maturation stages of the erythropoietic lin- 
eage. Erythroblasts and normoblasts express E-cad- 
herin, mature erythrocytes do not. A  functional role of 
E-cadherin in the differentiation process of the eryth- 
roid lineage was indicated by antibody-inhibition stud- 
ies. The addition of anti-E-cadherin antibody to bone 
marrow mononuclear cultures containing exogeneous 
erythropoietin drastically diminished the formation of 
erythropoietic cells. These data suggest a non-antici- 
pated expression and function of E-cadherin in one de- 
fined hematopoietic cell lineage. 
C 
ADHERINS are a family of structurally and function- 
ally related molecules which mediate homophilic, 
calcium-dependent cell-cell interactions (10). The 
classical cadherins to which the  E-, N-, and P-cadherins 
belong are highly conserved transmembrane glycoproteins 
with similar domains for adhesion sites, calcium binding 
and the interaction with the cytoskeleton (12). Recently, a 
second  class  of cadherins  was  identified  by polymerase 
chain reaction which differ from the classical eadherins by 
unique structural features (32, 33). Cadherins have been 
demonstrated to play major roles during morphogenesis 
(29), the maintenance of epithelial tissues and also in ma- 
lignant tumors (30). Most of these cadherin-dependent in- 
teractions are  homophilic as well as homotypie, but two 
recent publications also showed that these adhesion mole- 
cules can also be involved in heterotypic and even in het- 
erophilic interactions (5, 31). These two publications also 
demonstrated that bone marrow-derived, nonresident leu- 
kocytes can interact with epithelial tissues via an E-cad- 
herin mediated pathway. 
In the bone marrow hematopoietic progenitor cells pro- 
liferate and differentiate within  a  specific microenviron- 
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ment which comprises resident nonhematopoietic stromal 
cells, a complex extracellular matrix and various secreted 
cytokines (7, 8,  15).  Close interactions of the developing 
progenitor cells with this microenvironment are necessary 
for the controlled egress of the hematopoietic cells. Under 
normal  circumstances  only mature  cells  leave  the  bone 
marrow, immature cells, with  the exception of the  early 
pro-T-cells, are retained within the marrow (24). In con- 
trast,  during  leukemia  when  a  breakdown  of  adhesive 
mechanisms  occurs,  many  immature  blast  cells  are  re- 
leased  into  the  periphery (11).  Various  adhesion  mole- 
cules of different families including the integrins and mem- 
bers of the Ig superfamily (21, 26, 28, 34), but also adhesive 
and anti-adhesive molecules of the extraceUular matrix (4, 
15, 17-19, 23) have been implicated in the interactions of 
developing hematopoietic progenitors and their microen- 
vironment. So far, the cadherin family did not seem to play 
a role in these highly specific interactions. 
In an attempt to look for an involvement of cadherins in 
human hematopoiesis we screened messenger RNA of pu- 
rified human bone marrow cells by reverse transcriptase- 
PCR  (RT-PCR) 1 with  specific primers  for the  classical 
cadherins. Here, we report that E-cadherin, which is also 
known as uvomorulin (35) and mainly present on cells of 
1. Abbreviation used in this paper.  RT-PCR, reverse transcriptase PCR. 
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marrow cells. Using flow cytometric analysis and affinity 
column  separation  we  identified  this  subset  as  distinct 
maturation  stages  of  the  erythroid  lineage.  Functional 
studies indicated that E-cadherin plays an important role 
in the maturation of erythrocytes within the bone marrow. 
Material and Methods 
Hematopoietic Cells and Cell Lines 
Normal bone  marrow aspirates were obtained  after  informed consent 
from  healthy  donors  undergoing  harvest  for  allogeneic  bone  marrow 
transplantation. The bone marrow mononuclear cells were separated from 
mature erythrocytes and granulocytes by Percoll  density (1.077 g/ml) gra- 
dient centrifugation. Bone marrow cells from patients with myeloblastic 
acute leukemia (FAB classification  AML M2; reference 2) were obtained 
at the time of initial  diagnosis,  and the mononuclear cells were also puri- 
fied  by  density  gradient  centrifugation.  The  erythroleukemic cell  line 
K562 and the myeloblastic cell line KGla were those used in our previous 
studies (17-19).  The human epidermoid carcinoma cell line A431, which is 
known to express high levels  of E-cadherin, was used for control experi- 
ments. All these cell lines were grown in RPMI-1640  culture medium sup- 
plemented with 10% fetal calf serum. 
Long-term Bone Marrow Cultures 
5 ×  106 purified bone marrow mononuclear cells, either from healthy do- 
nors or from patients with myeloblastic AML M2 leukemia, were grown 
in 25 cm  2 tissue culture flasks in RPMI-1640  medium containing 12.5% fe- 
tal calf  serum, 12.5%  horse serum, and 10 -6 M  hydrocortisone (Dexter 
conditions). The  medium was changed completely every week.  Under 
these conditions an adherent stromal cell layer consisting of elongated fi- 
broblast-like cells  and macrophages is formed during a period of two to 
three  weeks. The  stromal cell  layer  supports myelopoiesis in  vitro for 
some weeks, but in the  absence of erythropoietin erythropoiesis is not 
supported by these culture conditions. For RT-PCR analysis  the stromal 
cell layer was harvested after 4 wk, when an almost confluent adherent 
stromal cell layer was present, after washing the long term culture twice 
with prewarmed PBS in order to remove most of the myeloid cells which 
adhere to the stromal cells. For immunofluorescence stainings the bone 
marrow ceils were grown on glass cover slips under the same culture con- 
ditions as described before. 
Antibodies 
The monoclonal antibody HECD-1 specific  for human E-cadherin (27) 
was purchased from Biermann  (Bad  Nauheim, FRG).  For use in  the 
CEPRATE LC biotin immunoaffinity column (see below) this antibody 
was biotinylated with a solution of I mg/ml N-thiosuccinimide biotin (Cal- 
biochem-Behring Corp., La Jolla, CA) in dimethyl sulfoxide.  Briefly,  10 
p~g of the biotin ester was added to 100 ixg/100 txl antibody in sodium bo- 
rate buffer, pH 9.3, and incubated for 2 h at room temperature. The reac- 
tion was stopped by the addition of 20 izl 1 M glycine. The biotinylated an- 
tibody was purified by gel filtration on a G-25 sephadex column (Pharmacia, 
Freiburg, FRG) 
Polymerase Chain Reaction 
Total RNA was isolated from bone marrow cells,  from long term bone 
marrow culture-derived stromal cells or from hematopoietic cell lines by 
acid guanidinium isothiocyanate-phenol-chloroform  extraction according 
to Chomczynski and Sacchi (6). E-cadherin and 13-acfin mRNAs were de- 
tected using RT-PCR methodology. Based on the published sequence for 
the human E-cadherin cDNA (3), specific sense (5'TCC ATT TCT TGG 
TCT ACG CC3')  and anti-sense (5'CAC CTT CAG CCA ACC TGT 
TT3')  primers corresponding to an extracellular  portion of E-cadherin 
were designed with the aid  of the HUSAR/GCG program from EMBL 
(Heidelberg, FRG), and were used to amplify a 362-bp PCR product from 
the positive control cell  line  A431.  The following primers amplifying a 
316-bp PCR product from human [3-actin cDNA were used: sense (5'TCA 
GAA GGA TTC  CTA TGT GGG C3')  and anti-sense (5'CCA TCA 
CGA TGC CAG TGG TA3'). Reverse transcription was performed with 
AMV-reverse transcriptase and buffers from Pharmacia at 42°C for 1 h 
with 3 pM anti-sense primers. PCR conditions with 2.5 U Taq-polymerase 
(Amersham-Buchler, Braunschweig, FRG) and 0.3 ~M of each primer in- 
cluded denaturation at 94°C for 30 s, annealing at 60°C for 1 min and poly- 
merisation at 72°C for 1 min, and a total of 33 cycles were run. PCR prod- 
ucts were resolved by electrophoresis in 2.3% agarose gels (GIBCO-BRL, 
Eggenstein, FRG) and detected  after ethidium bromide staining.  Reac- 
tions were carried out in the presence or absence of 1 Ixg total RNA. RT- 
PCR products were not detected if the RNA was omitted. 
FA  CS Analysis 
For single color immunofluorescence studies, 5 x  105 cells were incubated 
with 20 tzl human serum (RWD14 from Behring Werke, Marburg, FRG) 
for 15 min, washed with 0.1%BSA, 0.1%  NaN3 in PBS and incubated for 
30 min with the first antibody. After two washing steps the cells were incu- 
bated for 20 min with FITC-conjugated goat anti-mouse IgG (Fab')2 frag- 
ments (Dianova, Hamburg, FRG), washed, and analyzed for surface anti- 
gen expression using a FACScan  e flow cytometer and FACScan Research 
software (Becton Dickinson GmbH, Heidelberg, FRG). As a positive con- 
trol, the cells were labeled with the antibody W6/32.HL  which recognizes 
the  heavy  chain of MHC  class  I  antigens. An  inactive  variant of W6/ 
32.HL,  the antibody W6/32.HK,  was used as a negative control (1). By ex- 
cluding  propidium iodide permeable ceils only living ceils were analyzed. 
For two color FACS analysis the bone marrow mononuclear cells were 
labeled with the biotinylated HECD-1 antibody in combination with one 
of the  following antibody  conjugates:  CD2-PE,  CD3-PE,  CD10-FITC, 
CD13-PE,  CD19-FITC,  CD33-PE,  CD34-FITC,  CD56-PE,  and  CD71- 
FITC which were  all  purchased from Dianova  (Hamburg, FRG);  and 
CD41-FITC and glycophorin A-FITC which were obtained from Immu- 
notech (Marseille,  France). After washing the biotinylated HECD-1 was 
stained with either streptavidin-phycoerythrin (SA-PE; Dianova) or with 
streptavidin-QuantumRed  TM (SA-QR; Sigma,  Munich, FRG) depending 
on the second antibody which was conjugated either with FITC or with 
phycoerythrin. The two color analysis was performed on a FACS Vantage 
(Becton Dickinson, Heidelberg, FRG). 25,000 events of each probe were 
aquired after compensation of the fluorescence signals and evaluated with 
the Lysis II software obtained from Becton-Dickinson. 
Immunofluorescence Stainings 
5-~m frozen sections of native bone marrow, taken from the sternum of 
hematopoietic healthy patients, were cut on a cryostat (Reichert & Jung, 
Heidelberg, FRG). The sections were allowed to air dry for one hour and 
could be stored at -20°C until use. The sections, as well as the long-term 
bone marrow cultures grown on glass cover slips, were fixed at -20°C in 
acetone for five minutes. The fixed  sections or cultures were then incu- 
bated for one hour with HECD-1 in PBS  containing 0.1%  BSA.  After 
washing, the bound antibodies were detected by a Cy3TM-conjugated goat 
anti-mouse second antibody (Dianova) diluted 1:500. For localization  of 
cell nuclei,  the sections were counterstained with the dye 4',6-diamino-2- 
phenylindol-dihydrochloride (DAPI; Boehringer Mannheim, FRG) at 1 
~g/ml. After another wash, the stained tissue or ceils were mounted with 
elvanol embedding medium (16)  and examined under a  Zeiss axiophot 
photomicroscope equipped with epifluorescent optics.  Control stainings 
were done by omitting the first antibodies. No staining above background 
could be observed. 
Western Blot Analysis 
Isolated bone marrow mononuclear cells  or stromal cells  of long-term 
bone marrow cultures were centrifugated at 150 g for 5 min and washed 
with PBS.  Then, 0.5 ml ice-cold  detergent extraction buffer (1% NP-40, 
1% Triton X-100, 1 mM CaC12, 1 mM PMSF and 1 t~g/ml Aprotinin in 50 
mM Tris, pH 7.6) was added to the cell pellets.  After an incubation of 30 
min the crude protein extracts were centrifugated at 10,000 g for 10 min. 
The supernatants were mixed with 2:,< Laemmli's SDS sample buffer con- 
taining 1%  13-mercaptoethanol  and boiled for 5 min. Proteins were sepa- 
rated on a 10% polyacrylamide gel followed by transfer to nitrocellulose 
filter in a semidry transfer unit. Unspecific protein binding sites of the fil- 
ters were blocked with 2% Blocking Reagent (Boehringer-Mannheim) in 
TBS for 1 h at 37°C. The filters were then washed with 0.05% Tween-20 in 
TBS, and incubated with HECD-1 antibody for 1 h. Then the filters were 
washed again for 30 min (the wash solution was changed every 5 rain), in- 
cubated with HRP-conjugated anti-mouse immunoglobulins (Dako A/S, 
Glostrup, Denmark) for 30 min, and washed as described before. Bound 
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(Braunschweig, FRG). 
Bone Marrow Cell Separation (Cell Pro  TM Column) 
107 bone marrow mononuclear cells isolated by density gradient centrifu- 
gation were washed twice with 1% BSA in PBS (washing buffer) and incu- 
bated for 30 min with 2 o.g/ml biotinylated HECD-1 antibody. Then, un- 
bound antibodies were removed with washing buffer and the cells were 
loaded onto a  CEPRATE  LC biotin immunoaffinity column preequili- 
brated with 5% BSA in PBS (Cell Pro  TM column;  Cell Pro, Wezembeck- 
Oppem, Belgium). Non-labeled cells were rinsed off with PBS from the 
column. By gravity flow the biotin-labeled E-cadherin positive cells were re- 
tained on the avidin-coated beads of the column. They could be released by 
gently squeezing the column according to the manufacturer's instruction. 
Functional Assay 
In a 24-well plate 106 cells/well/ml of purified bone marrow mononuclear 
cells from healthy donors were cultured in the absence or presence of 5 U/ml 
erythropoietin (Terry  Fox  Laboratory,  Vancouver,  Canada)  in  RPMI- 
1640 culture medium containing 12.5%  horse serum, 12.5%  fetal calf se- 
rum, and 10 _6 M  hydrocortisone. To analyze a functional role of E-cad- 
herin, the mAb HECD-1 was added to the erythropoietin containing cul- 
tures at final concentrations of 0.5, 1.0, and 5.0 p~g/ml,  respectively. After 
16 d of culture a defined aliquot of the non-adherent cells was harvested 
and transferred by cytospin centrifugation to a slide and stained for 3 min 
with May-Griinwald staining-solution and 7  min with Giemsa-solution. 
The total number of the cells on the slide as well as the number of erythro- 
poietic cells were evaluated under a Zeiss axiovert microscope. All the ex- 
periments with cells of each donor were carried out in duplicate. 
Results 
Expression of  E-Cadherin by Bone Marrow 
Mononuclear Cells 
For an analysis of the expression of E-cadherin in the hu- 
man bone  marrow,  a  specific reverse transcriptase  poly- 
merase chain reaction with primers corresponding  to bp 
381-400  and  bp  723-742  of  the  human  E-cadherin  se- 
quence  (this  sequence  data  is  available  from  Genbank/ 
EMBL/DDBJ  under  accession  number Z13009)  was  es- 
tablished using RNA of the epithelial cell line A431  as a 
positive  control.  The  expected  362-bp  cDNA  fragment 
was amplified from RNA  of bone  marrow mononuclear 
cells, but not from RNA of normal bone marrow derived 
Figure 1.  RT-PCR analysis of E-cad- 
herin  expression  of  human  bone 
marrow derived cells. RNA  of iso- 
lated  bone  marrow  mononuclear 
cells without being cultured (lanes 1 
and 3) and of bone marrow derived 
stromal  cells  after  four  weeks  of 
culture  (lanes  2  and  4)  were  re- 
verse-transcribed  and  amplified 
with  human  E-cadherin  specific 
primers (lanes 1  and 2) and human 
13-actin specific primers (lanes 3  and 
4). After separation on a 2.3% agar- 
ose gel, a strong 362-bp signal could 
be detected in lane I  (bone marrow 
mononuclear  cells),  but  no  E-cad- 
herin  specific  signal  could  be  detected  with  RNA  from  bone 
marrow stromal cells (lane 2). Strong 316-bp 13-actin-specific sig- 
nals could be detected in both RNA preparations (lanes 3 and 4). 
Lane m  represents the 100-bp ladder. 
stromal cells after four weeks of culture (Fig. 1). Sequenc- 
ing of the PCR product from the bone marrow mononu- 
clear cells confirmed the identity to the published E-cad- 
herin  sequence.  In  control  RT-PCR  experiments  using 
specific  primers  for  human  [3-actin,  comparably  strong 
specific amplification products were obtained from RNA 
of the bone marrow mononuclear cells and the bone mar- 
row derived stromal cells indicating that both RNA prepa- 
rations  were  intact  (Fig.  1).  RT-PCR  analyses  of RNA 
from the  erythroleukemic cell line  K562  and  the  myelo- 
blastic cell line KGla, as well as from stromal cells derived 
from an AML-M2 myeloblastic leukemia patient also did 
not  show  any positive  signal  for E-cadherin  expression. 
Thus,  it  seemed  likely that  a  subpopulation  of the  non- 
adherent bone marrow cell fraction, which was lost during 
the 4-wk culture period, was the source of E-cadherin ex- 
pression. 
Western blot analysis with a human E-cadherin specific 
antibody  further  strengthened  this  observation.  Protein 
extracts were obtained from isolated bone marrow mono- 
nuclear cells and from the stromal cell layer of a  normal 
long term bone marrow culture after 4 wk of incubation. 
The stromal cell layer mainly consisted of fibroblast-like 
cells and macrophages. After immunoblotting, an E-cad- 
herin  specific band  of 120  kD  could  be  detected  in  the 
bone marrow mononuclear cell extract, but not in the ex- 
tract derived from bone marrow stromal cells (Fig. 2). As a 
control, an extract of the E-cadherin expressing epithelial 
cell line A431 was run in parallel resulting in a very strong 
signal at 120 kD (Fig. 2, lane c). 
To analyze the  expression of E-cadherin  in the  native 
bone  marrow,  immunofluorescence  stainings  of cryostat 
sections of this tissue were performed with the E-cadherin 
specific antibody HECD-1. Strong staining signals of indi- 
vidual hematopoietic cells, mainly at their cell surfaces, in- 
dicated  a  non-uniform  distribution  of E-cadherin  in  the 
human bone marrow (Fig. 3) which could not be attributed 
to morphologically identifiable specific cell typesl An ira- 
Figure  2.  Western  blot  analysis  of 
E-cadherin  expression  of  human 
bone marrow cells. Protein extracts 
of isolated  bone  marrow  mononu- 
clear cells (lane a), of bone marrow 
stromal  cells  after  4  wk  of culture 
(lane  b)  and  of  the  epithelial  cell 
line  A431  (lane  c)  were  separated 
on a 10% linear SDS-PAGE gel un- 
der reducing conditions. After trans- 
fer  to  nitrocellulose,  the  filter  was 
incubated  with  the  human  E-cad- 
herin  specific  antibody  HECD-1. 
Positive  signals  were  visualized  by 
the  ECL  method.  Bone  marrow 
stromal cells did not express E-cad- 
herin (lane b), but in the protein ex- 
tract of isolated bone marrow cells a 
distinct band of 120 kD could be de- 
tected (lane a). A  very strong signal 
was found in the control experiment 
with A431 cells which are known to 
express  high  levels  of  E-cadherin 
(lane e). 
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bone  marrow.  The  photographs  show  indirect  immunofluores- 
cence stainings  of human  bone marrow cryostat sections.  In  a, 
the  section is stained  with  the  human  E-cadherin  specific anti- 
body  HECD-1.  Distinct  stainings  of individual  cells, mainly  at 
their cell surfaces,  could  be  detected,  b  represents  the  control 
staining with the second antibody, the first antibody was omitted. 
Bar, 70 i~m. 
munofluorescence  staining  of an  adherent  bone  marrow 
stromal cell layer after 4 wk of culture did not show any 
positive staining signals (not shown) indicating again that 
these cells do not express E-cadherin. 
E-Cadherin Expression of Bone Marrow Cells Is 
Restricted to the Erythroid Lineage 
Isolated  bone  marrow  mononuclear  cells  were  labeled 
with the biotinylated mAb HECD-1 and applied to the bi- 
otin immunoaffinity Cell Pro  TM  column.  Through the  bi- 
otin-avidin interaction labeled ceils were retained in  the 
column and unlabeled cells could be washed off the col- 
umn. By gently squeezing the column the E-cadherin-pos- 
itive cells were released. A morphological analysis of these 
cells revealed that after a single run the majority consisted 
of precursors of the erythropoietic lineage, in particular a 
few erythroblasts and mainly normoblasts (Fig. 4). FACS 
analysis of normal bone marrow mononuclear cells showed 
that  10-15%  of the  cells  (depending  on  the  donor)  ex- 
pressed E-cadherin (Figs. 5 and 6 a). By two color flow cy- 
tometry analysis no coexpression of E-cadherin with lym- 
phoid  (CD2,  CD3,  CD10,  CD19,  CD56,  CD62L)  or 
Figure 4.  Isolation of E-cadherin expressing bone marrow cells. 
Bone marrow mononuclear cells isolated by density gradient cen- 
trifugation were labeled with the biotinylated HECD-1 antibody 
and applied to a Cell Pro  TM column. Unlabeled cells were rinsed 
off the column, and bound cells were released by gently squeez- 
ing the column. After cytospin preparation  the E-cadherin posi- 
tive cells were stained  according to Pappenheim  and  identified 
mainly  as  normoblasts  and  occasionally  as  erythroblasts.  The 
photograph  shows four typical normoblasts eluted from the col- 
umn.  These  cells  are  characterized  by  their  dense  chromatin 
structure and the homogeneous cytoplasm. Bar, 5 txm. 
myeloid (CD13,  CD33,  CD41)  cell surface marker mole- 
cules  could  be  detected  (Fig.  5).  Similarly,  CD34  which 
characterizes early differentiation stages of hematopoietic 
cells was absent on E-cadherin expressing cells. Co-expres- 
sion of E-cadherin was found for glycophorin A  and the 
transferrin receptor (CD71)  which  are marker molecules 
of the erythroid lineage in the normal bone marrow (Fig. 
5).  These results indicated  that  only cells of the  erythro- 
poietic  origin  carry  the  E-cadherin  molecule  in  the  he- 
matopoietic system.  E-cadherin  appeared  to  be  strongly 
expressed on erythroblasts which are normally included in 
the larger sized cell population gated in Fig. 6 c and to de- 
crease during maturation of the erythroid precursors into 
normoblasts which are usually found in the smaller sized 
cell population gated in Fig. 6 b (22). Mature erythrocytes 
did  not  express E-cadherin.  FACS  analysis of long-term 
bone marrow cultures also did not show any positive sig- 
nals for E-cadherin expression (not shown).  Without  the 
addition of exogeneous erythropoietin the differentiation 
process of erythroblasts is not supported by these culture 
conditions, only myeloid and stromal cell types are present 
in these cultures. The failure to detect any E-cadherin ex- 
pressing cells in these cultures after a 4-wk incubation pe- 
riod  confirmed  our  PCR  and  Western  blot  data  (see 
above, Figs. 1 and 2). 
Inhibition of  Erythropoietic Differentiation 
To support erythropoietic differentiation in bone marrow 
short term cultures 5 U/ml of erythropoietin was added to 
the culture medium. Without  the  addition  of erythropoi- 
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etin only very few erythroblasts and normoblasts could be 
detected after a culture period of 16 d (Fig. 7). However, 
in the presence of exogeneous erythropoietin up to 50% of 
the cells differentiated into erythroblasts and normoblasts 
during  this  incubation time  as judged  by morphological 
criteria.  The  addition  of  the  anti-E-cadherin  antibody 
HECD-1  to  the  erythropoietin-containing  cultures  re- 
duced the numbers of erythropoietic cells in a dose-depen- 
dent manner: 5/xg/ml of the antibody decreased the for- 
mation of erythropoietic cells  almost  to  the  level of the 
cultures grown in the  absence of erythropoietin (Fig.  7). 
Toxicity of the antibody seemed very unlikely since the to- 
tal cell numbers did not significantly differ in the presence 
or absence of the antibody and almost no dead cells were 
found in the antibody-containing cultures after 16 d of in- 
cubation. 
Discussion 
Members of the cadherin family are known to function as 
morphoregulatory  proteins  during  embryonic  develop- 
FUE-X,4'tZ-tttt~¢ ---> 
CDI3-PE 
13.1~  0.14 
t  -  9.14 
CD56-PE 
Figure  5.  Two  color  FACS  analysis of 
bone marrow mononuclear  cells. The bi- 
otinylated  HECD-1  antibody and the di- 
rectly FITC- or PE-conjugated second an- 
tibodies  against  the  different  lymphoid, 
myeloid, early progenitors  and  erythroid 
cell surface marker molecule were used to 
label the isolated bone marrow mononu- 
clear  cells. The  biotinylated  anti-E-cad- 
herin  antibody  was  detected  either  by 
streptavidin-phycoerythrin  (PE)  or  by 
streptavidin-QuantumRed  TM (QR). Dou- 
ble-positive ceils could be found in the up- 
per right quadrant. 
ment, and are important in the maintenance of tissue in- 
tegrity and in tumorogenesis (12, 25, 29, 30). Thus far, no 
involvement  of  cadherins  in  the  hematopoietic  system 
with its high turnover of cells has been reported.  In the 
present study we demonstrated that E-cadherin, which is 
known to be synthesized mainly by polar epithelial cells, is 
transiently expressed on defined stages of the erythropoi- 
etic cell lineage. This was observed despite the obviously 
nonpolar structure of the erythropoietic cells.  E-cadherin 
seems to be  involved in regulating erythroid differentia- 
tion processes, because antibodies against E-cadherin in- 
hibited erythropoietic differentiation in vitro. 
A first hint of the involvement of the classical cadherins 
(E-,  P-,  N-cadherin)  in  the  hematopoietic  system  was 
found by PCR analysis of the heterogeneous bone marrow 
cell population. By this method all  three cadherins were 
found  to  be  present  in  human  bone  marrow  aspirates 
(Armeanu,  S.,  and  G.  Klein,  unpublished  observations), 
but only for E-cadherin we were able so far to define ex- 
actly  the  hematopoietic  cell  types  in  the  bone  marrow 
which express this molecule. 
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Figure  6.  Single  color  flow 
cytometry  analysis  of  bone 
marrow  mononuclear  cells. 
The  figures  show  three  dif- 
ferent  gatings of bone  mar- 
row  cells  labeled  with 
HECD-1  in  the  FSC/SSC 
dot blot displays and the cor- 
responding  FACS  histo- 
grams  demonstrating  the 
intensity  of  E-cadherin  ex- 
pression. The largest gate set 
in A contained about 15% of 
cells  of  the  heterogeneous 
cell  population  which  ex- 
pressed E-cadherin with dif- 
ferent intensities. Gating on 
the  larger cell types  (1.3%) 
revealed that  these cells ex- 
pressed  E-cadherin  with  a 
much higher intensity (C) as 
compared to the smaller cell 
types  analyzed  in  B.  The 
dashed line in the histogram 
represents the  negative con- 
trol with the W6/32.HK anti- 
body,  the  continuous  line 
represents  the  labeling with 
the HECD-1 antibody. 
Expression of E-cadherin was shown to be restricted to 
the  erythroid  lineage  by  immunoaffinity  separation  of 
bone marrow cells with the mAb HECD-1 which lead to a 
selective enrichment of erythroblasts and normoblasts. These 
progenitor cell types were comprised in the gates contain- 
ing also the E-cadherin positive cells in the flow cytometry 
Erythropoiesis  in  tong  term  bone  marrow  culture 
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Figure 7.  Anti-human E-cadherin specific antibodies inhibit dif- 
ferentiation of erythropoietic progenitors into erythroblasts and 
normoblasts. 106 isolated bone  marrow mononuclear cells/well 
were cultured in the presence (Epo +) or absence (Epo -) of 5 U/ml 
erythropoietin. Without this cytokine, only very few erythropoi- 
etic cells could be detected after 16 d of culture. The presence of 
erythropoietin stimulated  the  differentiation of erythropoietic 
cells drastically, up  to 50%  of the cells could be identified as 
erythroblasts and normoblasts. The addition of the mAb HECD-1 
decreased the formation of these erythropoietin-induced eryth- 
ropoietic cells in a concentration-dependent manner, only 12% 
(+/-3%) of the cells were of erythropoietic origin in the presence 
of 5 ixg/ml anti-E-cadherin antibody. The experiments were car- 
ried out in duplicate. 
analysis (22). A  higher labeling of E-cadherin appeared to 
be present on the larger erythroblasts than on the eryth- 
roid precursors of the smaller normoblast stage suggesting 
gradual loss of its expression during maturation.  Double 
labeling  experiments  with  the  anti-E-cadherin  antibody 
and  various  myeloid and  lymphoid cell surface  markers 
only  revealed  coexpression  with  the  molecules  glyco- 
phorin A  and CD71, the transferrin receptor, as two typi- 
cal erythroid marker antigens. Bone marrow derived stromal 
cells encompassing fibroblast-like cells and  macrophages 
did not express E-cadherin as shown by RT-PCR,  West- 
ern blot analysis, and immunofluorescence staining of ad- 
herent stromal layers. Thus, E-cadherin seemed only to be 
synthesized by cells of the erythroid origin within the hu- 
man bone marrow. 
As another type of bone marrow-derived cells express- 
ing E-cadherin the murine Langerhans cells of the epider- 
mis have been identifed and shown to interact with kera- 
tinocytes in a  homotypic fashion  via E-cadherin  (30).  A 
similar homotypic interaction of erythropoietic progenitor 
cells with  another  cell type  in  the  human  bone  marrow 
seems unlikely since we could not detect another E-cad- 
herin positive bone  marrow cell. Normally, erythroblasts 
differentiate  in  close  association  with  a  central  macro- 
phage in a  structure called the erythroblastic islands (13, 
22).  Macrophages  of  bone  marrow  aspirates  of  in  vitro 
long term  cultures  did not  show  any E-cadherin expres- 
sion. Therefore, interaction of erythroblasts with the cen- 
tral macrophage  via E-cadherin seems  to be unlikely al- 
though  we  cannot  exclude with certainty that  the single 
central macrophage of the erythroblastic island represents 
a specialized bone marrow cell type with specific differen- 
tiation characteristics and surface adhesion molecules. 
A  heterotypic heterophilic interaction involving E-cad- 
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traepithelial lymphocytes with aEI37 as the counter recep- 
tor  (5).  Up  to  now no  aE[37  expressing  cells  have  been 
demonstrated in the human bone marrow still restricting 
expression of this integrin type to intraepithelial lympho- 
cytes (9).  Clearly, macrophages present in the bone mar- 
row have to be analyzed for  az137 integrin expression. 
By  addition  of  the  mAb  HECD-1  to  bone  marrow 
mononuclear cultures in the presence of erythropoietin we 
could demonstrate a  strong inhibitory effect of this anti- 
body  on  erythroid  differentiation.  Addition  of  the  anti- 
body to the cell cultures did not lead to an induction of the 
differentiation process indicating that binding of the anti- 
body  could  not  serve  as  a  substitute  for  the  ligand  of 
E-cadherin on erythropoietic cells. However, it is not clear 
whether differentiation of the erythroblasts is a molecular 
event triggered by cell-cell adhesion. Members of the cad- 
herin family are mainly thought to be involved in mediat- 
ing  cell  adhesive  interactions,  but  through  their  interac- 
tions with  the  cytoplasmic catenins  (14)  these  molecules 
could also be involved in major signal transduction events. 
Thus, it might be possible that E-cadherin does not func- 
tion as an adhesion-mediating  molecule and is therefore 
not important for the retention of erythropoietic cells in 
the bone marrow. Instead, E-cadherin might have a major 
role as a  signal  transduction molecule in this differentia- 
tion process. 
To our knowledge we have shown here for the first time 
an involvement of one member of the cadherin family dur- 
ing hematopoietic lineage maturation. The expression and 
function of E-cadherin was certainly not anticipated and a 
major task for the  future will be  to define  the  ligand  of 
E-cadherin on erythropoietic cells. This ligand may either 
be  E-cadherin itself or it could be  a heterophilic interac- 
tion.  Other members  of the  cadherin family can  also be 
functionally  involved  in  hematopoiesis  and  the  present 
study shows that the search for other cadherin molecules 
in the hematopoietic system is certainly justified. 
We thank Inge Steiert for preparing the E-cadherin specific primers. 
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